Cargando…
MON-321 Metastatic Melanoma with Unknown Primary Site in a Patient with Multiple Endocrine Neoplasia Type 1
Background: MEN1 is a rare hereditary tumor syndrome caused by germline inactivating mutations of the tumor suppressor gene MEN1 and is characterized by a predisposition to endocrine tumors primarily of parathyroid, enteropancreatic, and anterior pituitary origin, as well as nonendocrine neoplasms....
Autores principales: | Kamilaris, Crystal, Mandl, Adel, Simonds, William, Weinstein, Lee, Agarwal, Sunita, Blau, Jenny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550817/ http://dx.doi.org/10.1210/js.2019-MON-321 |
Ejemplares similares
-
Thymoma and Not Just Thymic Carcinoid Can Be Associated With Multiple Endocrine Neoplasia Type 1
por: Graf, Akua, et al.
Publicado: (2021) -
MON-LB055 A Single Center Experience of Multiple Endocrine Neoplasia Type 1 (MEN1) vs Sporadic Insulinoma: What Can We Learn and Where Are We Going?
por: Itatani, Miho, et al.
Publicado: (2019) -
SUN-116 The Role of (68)Gallium DOTATATE PET/CT Versus (18)F-FDOPA PET/CT in the Imaging of Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1 (MEN1)
por: Tepede, Aisha, et al.
Publicado: (2020) -
SUN-128 Impaired Fasting Glucose Is Associated with Insulin Resistance in Patients with Germline Mutations in the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene
por: Bansal, Rashika, et al.
Publicado: (2020) -
SAT-LB060 Clinical Presentation and Management of Primary Ovarian Carcinoids in Multiple Endocrine Neoplasia Type 1
por: Jhawar, Sakshi, et al.
Publicado: (2019)